Extensive evidence suggests that IDO is associated with immune checkpoint(s) in many cancers [36–38], and our findings reveal the promotion of CD8+ T cell exhaustion via IDO mediated by CSCC-remodelled LECs. This evidence concerns the gene IDO1 and cancer.